NEW YORK (GenomeWeb) – Sygnis today announced it has signed a non-exclusive distribution agreement with Japanese firm Funakoshi. 

Under the terms of the agreement, Sygnis has granted Funakoshi the rights to promote, market, and sell all existing and future products based on its TruePrime single-cell total genome amplification technologies in Japan.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The Jackson Laboratory has filed a complaint accusing Nanjing University of breeding and re-selling its mouse models, the Hartford Courant reports.

Oxford researchers are turning to virtual reality to visualize genes and regulatory elements, says.

In Science this week: neutrophils rely on microRNA to protect against lung inflammation, and more.

China is moving forward with plans to sequence a million citizens, the Wall Street Journal reports.